ArticleMedical care2026
Racial and Ethnic Differences in COVID-19 Disease Severity Among US Adults in Health Systems Participating in PCORnet®: May 2020-October 2022.
Article in Medical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PCORnet®: Accelerating Patient-Centered Comparative Clinical Effectiveness Research.Medical care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study analyzed COVID-19 disease severity distributions among different age, racial, and ethnic groups for pre-Omicron and Omicron variant periods from May 2020 to October 2022. Disease severity categories were defined by ICD-10-CM diagnostic codes recorded in the electronic health record in the 7 days preceding and 13 days following the SARS-CoV-2 positive laboratory record (index date) and were grouped into 4 mutually exclusive categories: severe complications, high, moderate, and low disease severity. Low severity was defined as the absence of codes for any of the other categories. Among 1,613,706 included patients, there was a lower prevalence of disease severity during the Omicron variant period across all race and ethnicity groups (P<0.001) compared with the pre-Omicron variant period; however, the Omicron period had a higher prevalence of severe complications (P<0.05). Relative to White patients with high disease severity, Black patients and patients of other races had 37.1% and 52.4% (Pt<0.0001) greater risk of having high disease severity, respectively, in the pre-Omicron period, but high disease severity was similar across racial groups during the Omicron period. During pre-Omicron, mean monthly relative differences among Hispanic patients with high disease severity and severe complications compared with non-Hispanic patients were -5.17% and -39.4%, respectively, which shifted to 24.4% and 44.1% in the Omicron period (Pt<0.0001). These findings provide valuable insight into patterns of COVID-19 disease severity, especially for marginalized populations, and highlight the need for targeted public health strategies as variant-specific trends evolve over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.